Treatment News : Task Force Recommends Hep B Tests For Those At Risk

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » June 2014

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

June 2, 2014

Task Force Recommends Hep B Tests For Those At Risk

The U.S. Preventive Services Task Force (USPSTF) has recommended screening for those at high risk of hepatitis B virus (HBV) infection, MedPage Today reports. Publishing the recommendation in Annals of Internal Medicine, the task force has moved away from its 2004 stance that the test’s potential harms trumped its potential benefits.

The change in policy, which was prompted in part by increasing evidence of the apparent benefits of suppressing hep B, brings USPSTF into the same camp as the Centers for Disease Control and Prevention (CDC), the American Association for the Study of Liver Diseases and the Institute of Medicine.

In addition to pregnant women, for whom USPSTF recommended screening in 2009, the high risk categories include:

  • Those born in countries with a 2 percent or greater hep B prevalence.
  • Those born in the US who were not vaccinated during infancy and whose parents emigrated from a country with a high hep B prevalence.
  • People living with HIV.
  • Injection drug users.
  • Those who have household contact with someone living with hep B.
  • Men who have sex with men.
To read the MedPage Today story, click here.

To read the recommendations, click here.

Search: U.S. Preventive Services Task Force, USPSTF, MedPage Today, Annals of Internal Medicine, hepatitis B, testing, HIV.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    andais
    Red House
    West Virginia


    juliar33
    brooklyn
    New York


    latinpozdallas
    Dallas
    Texas


    pozsmith1
    East Bay
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.